Mattaini, Katherine R.
Sullivan, Mark R.
Lau, Allison N.
Fiske, Brian P.
Bronson, Roderick T.
Vander Heiden, Matthew G. http://orcid.org/0000-0002-6702-4192
Funding for this research was provided by:
National Cancer Institute (CA198028, CA168653)
Article History
Received: 24 October 2018
Accepted: 12 July 2019
First Online: 22 July 2019
Ethics approval and consent to participate
: All mouse studies were performed in accordance with institutional guidelines and approved by the MIT Committee on Animal Care under protocols 0113–006-16 (approved in 2013), 1115–110-18 (approved in 2015), and 0119–001-22 (approved in 2019).
: Not applicable.
: M.G.V.H. is on the scientific advisory board of Agios Pharmaceuticals, Aeglea Biotherapeutics, and Auron Therapeutics. The other authors declare no competing interests.